Timing of Mortality After Severe Bleeding and Recurrent Myocardial Infarction in Patients With ST-Segment-Elevation Myocardial Infarction

被引:27
|
作者
Kikkert, Wouter J. [1 ]
Zwinderman, Aeilko H. [2 ]
Vis, Marije M. [1 ]
Baan, Jan, Jr. [1 ]
Koch, Karel T. [1 ]
Peters, Ron J. [1 ]
de Winter, Robbert J. [1 ]
Piek, Jan J. [1 ]
Tijssen, Jan G. P. [1 ]
Henriques, Jose P. S. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands
关键词
major bleeding; primary percutaneous coronary intervention; recurrent myocardial infarction; ST-segment-elevation myocardial infarction; PERCUTANEOUS CORONARY INTERVENTION; ACUITY ACUTE CATHETERIZATION; AMI HARMONIZING OUTCOMES; PRIMARY ANGIOPLASTY; CLINICAL-OUTCOMES; BLOOD-TRANSFUSION; TRIAGE STRATEGY; CLOPIDOGREL; PREDICTORS; IMPACT;
D O I
10.1161/CIRCINTERVENTIONS.113.000425
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The prognosis of initial survivors of ST-segment-elevation myocardial infarction (STEMI) is affected by both recurrent myocardial infarction (MI) and severe bleeding. The aim of the current study was to investigate how mortality is affected in time after bleeding and recurrent MI. Methods and Results-From January 1, 2003, to July 31, 2008, a total of 2002 patients were treated with primary percutaneous coronary intervention for ST-segment-elevation MI and followed up for the occurrence of recurrent MI and Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) severe bleeding. Primary outcome was all-cause mortality within 4 years of follow-up. In a time-dependent, covariate-adjusted Cox regression model, both bleeding and recurrent MI were associated with an increase in mortality shortly after the adverse event: hazard ratio, 14.37 (95% confidence interval [CI], 7.69-26.84) for the first day after recurrent MI and 5.42 (95% CI, 2.88-10.22) for the first day after bleeding. Thereafter the risk of subsequent mortality gradually decreased but remained elevated long after a recurrent MI (hazard ratio, 4.95 [95% CI, 3.27-7.48] between 1 day and 1 year after recurrent MI and hazard ratio, 2.56 [95% CI, 1.56-4.21] beyond 1 year after recurrent MI), but decreased to nonsignificant level beyond 1 month after the bleeding (hazard ratio, 0.56 [95% CI, 0.27-1.14]). Conclusions-The occurrence of both recurrent MI and bleeding in the first year after ST-segment-elevation MI is associated with subsequent mortality. The risk implication of recurrent MI, however, was greater and more sustained over time than that of severe bleeding.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 50 条
  • [31] Comparative Effectiveness of ST-Segment-Elevation Myocardial Infarction Regionalization Strategies
    Concannon, Thomas W.
    Kent, David M.
    Normand, Sharon-Lise
    Newhouse, Joseph P.
    Griffith, John L.
    Cohen, Joshua
    Beshansky, Joni R.
    Wong, John B.
    Aversano, Thomas
    Selker, Harry P.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (05): : 506 - 513
  • [32] Microthrombi and ST-Segment-Elevation Myocardial Infarction in COVID-19
    Guagliumi, Giulio
    Sonzogni, Aurelio
    Pescetelli, Irene
    Pellegrini, Dario
    Finn, Aloke V.
    CIRCULATION, 2020, 142 (08) : 804 - 809
  • [33] Prehospital Delay After Acute ST-Segment-Elevation Myocardial Infarction in Beijing, China
    Hu, Dayi
    Yang, Jingang
    Pi, Lin
    Sun, Yihong
    CIRCULATION, 2010, 122 (02) : E57 - E57
  • [34] "Goldilocks" Approach to Deferred Stenting in ST-Segment-Elevation Myocardial Infarction
    Yong, Celina M.
    Tamis-Holland, Jacqueline E.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (10):
  • [35] Oxygen for ST-Segment-Elevation Myocardial Infarction Still Up in the Air
    Nedeljkovic, Zoran S.
    Jacobs, Alice K.
    CIRCULATION, 2015, 131 (24) : 2101 - 2103
  • [36] Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction
    James, Stefan
    Koul, Sasha
    Andersson, Jonas
    Angeras, Oskar
    Bhiladvala, Pallonji
    Calais, Fredrik
    Danielewicz, Mikael
    Frobert, Ole
    Grimfjard, Per
    Gotberg, Matthias
    Henareh, Loghman
    Ioanes, Dan
    Jensen, Jens
    Linder, Rikard
    Lindroos, Pontus
    Omerovic, Elmir
    Panayi, Georgios
    Ramunddal, Truls
    Sarno, Giovanna
    Ulvenstam, Anders
    Voltz, Sebastian
    Wagner, Henrik
    Wikstrom, Helena
    Ostlund, Ollie
    Erlinge, David
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (12) : E008969
  • [37] Burden of Multimorbidity in Young Women With ST-Segment-Elevation Myocardial Infarction
    Tran, Linh
    Minhas, Anum
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (07):
  • [38] The impact of fibrinolytic therapy for ST-segment-elevation acute myocardial infarction
    Van De Werf, F. J.
    Topol, E. J.
    Sobel, B. E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (01) : 14 - 20
  • [39] Is the 6-month mortality rate similar in st-segment-elevation and non-ST-segment-elevation myocardial infarction?
    Faria, R.
    Mimoso, J.
    Marques, N.
    Trigo, J.
    Marques, V.
    Gomes, V.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0F) : F60 - F60
  • [40] Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction and Concurrent Active Gastrointestinal Bleeding
    Mohar, Dilbahar S.
    Seto, Arnold H.
    Kern, Morton J.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (10)